Description

Schedule of activities for acquisition window (takeover) of J B Chemicals & Pharmaceuticals Ltd shares from November 18 to December 1, 2025, with offer price of Rs. 1,639.18 per share for up to 4,17,45,264 equity shares.

Summary

BSE has announced the schedule for an Offer to Buy – Acquisition Window (Takeover) for J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM). The offer will run from November 18, 2025, to December 1, 2025, allowing acquisition of up to 4,17,45,264 equity shares at Rs. 1,639.18 per share. Trading members and custodian members must follow prescribed timelines and procedures for bid offering, give-up, and take-up activities through iBBS and RTRMS platforms.

Key Points

  • Security Details: J B Chemicals & Pharmaceuticals Ltd (Symbol: JBCHEPHARM, Scrip Code: 506943, ISIN: INE572A01036)
  • Offer Size: Up to 4,17,45,264 equity shares
  • Offer Price: Rs. 1,639.18 per share
  • Face Value: Rs. 1.00 per share
  • Market Lot: 1 share
  • Offer Period: November 18, 2025 (Tuesday) to December 1, 2025 (Monday)
  • Bid Offering Period: 9:15 AM to 3:30 PM daily during offer period
  • Give-up Period: November 18 to November 28, 2025 (9:15 AM to 3:30 PM); Last day December 1, 2025 (9:15 AM to 3:30 PM)
  • Take-up Period: November 18 to November 28, 2025 (9:15 AM to 3:30 PM); Last day December 1, 2025 (9:15 AM to 4:00 PM)

Regulatory Changes

No regulatory changes introduced. This circular provides operational guidelines for participation in the takeover offer under existing OTB framework as per Exchange Notices 20150930-1 (September 30, 2015) and 20170203-29 (February 3, 2017).

Compliance Requirements

For Trading Members and Custodians:

  • Ensure investor UCC is registered and updated with correct PAN number and category in Exchange UCC database
  • Trading members can only bid for investors holding shares in demat form
  • Access OTB module through designated iBBS and RTRMS platforms (both internet and leased line URLs provided)
  • Access Extranet for files acceptance after receiving confirmation from Merchant Banker/RTA post-issue closure
  • Note that if no securities are accepted, no End of Issue files will be generated in Extranet

Investor Categories Eligible for Bidding:

  • Foreign Institutional Investors (FII)
  • Financial Institutions (FI)
  • Mutual Funds (MF)
  • Insurance Companies (IC)
  • Other QIBs (OTH)
  • Other Non-Institutional Buyers (NOH)
  • Companies (CO)
  • Individuals (IND)

Important Dates

  • November 14, 2025: Notice date
  • November 18, 2025: Opening date - Bid offering, give-up, and take-up commence (9:15 AM)
  • November 18-28, 2025: Give-up and take-up period (9:15 AM to 3:30 PM daily)
  • December 1, 2025: Closing date
    • Bid offering: 9:15 AM to 3:30 PM
    • Give-up (last day): 9:15 AM to 3:30 PM
    • Take-up (last day): 9:15 AM to 4:00 PM (extended by 30 minutes)

Impact Assessment

Market Impact: High - This is a significant takeover offer involving over 4.17 crore equity shares of J B Chemicals & Pharmaceuticals Ltd at a fixed price of Rs. 1,639.18 per share, representing substantial value and potential change in ownership structure.

Operational Impact: Trading members and custodians must prepare systems and processes for OTB participation, ensure proper UCC registration for clients, and manage bidding activities across the 14-day offer period. Members need to coordinate with multiple BSE platforms (iBBS, RTRMS, Extranet) using provided URLs.

Investor Impact: Shareholders of JBCHEPHARM have the opportunity to tender their shares in this acquisition window at the specified offer price. Only demat holdings can participate through registered trading members.

Contact Support: BSE has provided comprehensive contact details for Trading Operations (022-22728005) and Listing Sales teams for technical assistance with iBBS, RTRMS, password resets, and OTB module queries.

Impact Justification

Takeover offer involving significant share volume (4.17 crore shares) with specific bidding procedures and strict timelines affecting trading members, custodians, and investors